Role of native-state topology in the stabilization of intracellular antibodies

Biophysical Journal

Volumn 81, Issue 5, 2001, Pages 2935-2945

  Settanni, Giovanni ^a,b   Cattaneo, Antonino ^a,b   Maritan, Amos ^a,b,c  

^a SISSA   (Italy)

^b INFM   (Italy)

^c ABDUS SALAM INTERNATIONAL CENTRE FOR THEORETICAL PHYSICS   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; CELL ANTIBODY; IMMUNOGLOBULIN;

AMINO ACID SEQUENCE; ANTIBODY STRUCTURE; ARTICLE; CYTOPLASM; DISULFIDE BOND; GENE MUTATION; GENETIC CONSERVATION; GEOMETRY; IMMUNOGLOBULIN VARIABLE REGION; MOLECULAR DYNAMICS; PROTEIN FOLDING; PROTEIN STABILITY; SITE DIRECTED MUTAGENESIS;

EID: 0034753250     PISSN: 00063495     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-3495(01)75933-4     Document Type: Article

References (56)

1. Prediction of protein-folding mechanisms from free-energy landscapes derived from native structures
2. Computational approach to the protein-folding problem
3. Expression and targeting of intracellular antibodies in mammalian cells
4. Intracellular expression of anti-p21ras single chain Fv fragments inhibits meiotic maturation of Xenopus oocytes
5. Redox state of single chain Fv fragments targeted to the endoplasmic reticulum, cytosol and mitochondria
6. Single-chain antigen-binding proteins
7. CHARMM: A program for macromolecular energy, minimization, and dynamics calculations
8. The mode of action of Y13-259 scFv fragment intracellularly expressed in mammalian cells
9. Intracellular Antibodies: Development and Applications
10. The selection of intracellular antibodies
11. Molecular dynamics studies on HIV-1 protease: Drug resistance and folding pathways
12. Mutational analysis of acylphosphatase suggests the importance of topology and contact order in protein folding
13. Topological and energetic factors: What determines the structural details of the transition state ensemble and "en-route" intermediates for protein folding? An investigation for small globular proteins
14. Molecular and virological effects of intracellular anti-Rev single-chain variable fragments on the expression of various human immunodeficiency virus-1 strains
15. Optimized Monte Carlo data analysis
16. The molecular basis of cooperativity in protein folding. Thermodynamic dissection of interdomain interactions in phosphoglycerate kinase
17. A soluble immunoglobulin variable domain without a disulfide bridge: Construction, accumulation in the cytoplasm of Escherichia coli, purification and physicochemical characterization
18. A theoretical search for folding/unfolding nuclei in three-dimensional protein structures
19. Inhibition of murine leukaemia virus retrotranscription by the intracellular expression of a phage-derived anti-reverse transcriptase antibody fragment
20. Molecular and cellular aspects of thiol-disulfide exchange
21. Theoretical studies of protein folding
22. The role of the intrachain disulfide bond in the conformation and stability of the constant fragment of the immunoglobulin light chain
23. Keeping it in the family: Folding studies of related proteins
24. Protein engineering of antibody binding sites: Recovery of specific activity in an anti-digoxin single-chain Fv analogue produced in Escherichia coli
25. Oxidized redox state of glutathione in the endoplasmic reticulum
26. Immunoglobulin-like modules from titin I-band: Extensible components of muscle elasticity
27. Kabat database and its applications: 30 Years after the first variability plot
28. Improving in vivo folding and stability of a single-chain Fv antibody fragment by loop grafting
29. Immunoglobulin mutant library genetically screened for folding stability exploiting bacterial signal transduction
30. The nature of antibody heavy chain residue H6 strongly influences the stability of a VH domain lacking the disulfide bridge
31. Intracellular antibodies (intrabodies) as research reagents and therapeutic molecules for gene therapy
32. Geometrical aspects of protein folding
33. Role of secondary motifs in fast folding polymers: A dynamical variational principle
34. Optimal shapes of compact strings
35. Expression of an antibody fragment at high levels in the bacterial cytoplasm
36. Obligatory steps in protein folding and the conformational diversity of the transition state
37. Inhibition of HIV-1 Tat-mediated LTR transactivation and HIV-1 infection by anti-Tat single chain intrabodies
38. Protein structures and optimal folding from a geometrical variational principle
39. A statistical mechanical model for beta-hairpin kinetics
40. Disrupting the hydrophobic patches at the antibody variable/constant domain interface: Improved in vivo folding and physical characterization of an engineered scFv fragment
41. Exploring local and non-local interactions for protein stability by structural motif engineering
42. Amber, a package of computer programs for applying molecular mechanics, normal-mode analysis, molecular-dynamics and free-energy calculations to simulate the structural and energetic properties of molecules
43. A natural antibody missing a cysteine in VH: Consequences for thermodynamic stability and folding
44. Antibody scFv fragments without disulfide bonds made by molecular evolution
45. Intracellular antibodies: Development and therapeutic potential
46. Functional antibody lacking a variable-region disulfide bridge
47. The role of topology in immunoglobulin variable domain
48. Transgenic plants expressing a functional single-chain Fv antibody are specifically protected from virus attack
49. Can a pairwise contact potential stabilize native protein folds against decoys obtained by threading?
50. Selection of antibodies for intracellular function using a two-hybrid in vivo system
51. The immunoglobulin superfamily: Domains for cell surface recognition
52. Navigating the folding routes
53. Mutual stabilization of VL and VH in single-chain antibody fragments, investigated with mutants engineered for stability
54. Different equilibrium stability behavior of ScFv fragments: Identification, classification, and improvement by protein engineering